BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets 2018;22:263-77. [PMID: 29447008 DOI: 10.1080/14728222.2018.1439924] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 25.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang DQ, Deng Y, Zhang LJ, Li LM, Qi Y, Wang J, Wang R, Zhai H, Zhao P, Yang L. Elevated resistin levels may regulate high mobility group box 1 expression in Guillain-Barré syndrome. J Neuroimmunol 2019;330:59-66. [PMID: 30826699 DOI: 10.1016/j.jneuroim.2019.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Fassi EMA, Sgrignani J, D'Agostino G, Cecchinato V, Garofalo M, Grazioso G, Uguccioni M, Cavalli A. Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex. Comput Struct Biotechnol J 2019;17:886-94. [PMID: 31333815 DOI: 10.1016/j.csbj.2019.06.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Miao L, Huang F, Sun YY, Jiang W, Chen YJ, Zhang M. Curcumin plays a local anti-inflammatory and antioxidant role via the HMGB1/TLR4/NF-ΚB pathway in rat masseter muscle under psychological stress. J Oral Rehabil 2021. [PMID: 34865233 DOI: 10.1111/joor.13289] [Reference Citation Analysis]
4 Ye Z, Jia J, Lv Z, Zheng S. Identification of High-Mobility Group Box 1 (HMGB1) Expression as a Potential Predictor of Rejection and Poor Prognosis After Liver Transplantation. Ann Transplant 2021;26:e931625. [PMID: 34282108 DOI: 10.12659/AOT.931625] [Reference Citation Analysis]
5 Bi X, Yan X, Jiang B, Liang J, Zhou J, Lu S, Liu J, Luo L, Yin Z. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses. Toxicol Appl Pharmacol 2021;433:115778. [PMID: 34755645 DOI: 10.1016/j.taap.2021.115778] [Reference Citation Analysis]
6 Huang CM, Cai JJ, Jin SW, Lin QC, Fang QJ, Nan K, Han Y, Ge WW, Liu Y, Tao YX, Cao H, Li J. Class IIa HDAC Downregulation Contributes to Surgery-Induced Cognitive Impairment Through HMGB1-Mediated Inflammatory Response in the Hippocampi of Aged Mice. J Inflamm Res 2021;14:2301-15. [PMID: 34103963 DOI: 10.2147/JIR.S304060] [Reference Citation Analysis]
7 Bhat SM, Massey N, Karriker LA, Singh B, Charavaryamath C. Ethyl pyruvate reduces organic dust-induced airway inflammation by targeting HMGB1-RAGE signaling. Respir Res 2019;20:27. [PMID: 30728013 DOI: 10.1186/s12931-019-0992-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhang D, Gao M, Jin Q, Ni Y, Zhang J. Updated developments on molecular imaging and therapeutic strategies directed against necrosis. Acta Pharm Sin B 2019;9:455-68. [PMID: 31193829 DOI: 10.1016/j.apsb.2019.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
9 Adil MS, Verma A, Rudraraju M, Narayanan SP, Somanath PR. Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection. J Cell Physiol 2021;236:6597-606. [PMID: 33624300 DOI: 10.1002/jcp.30343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gran ER, Bertorelle F, Fakhouri H, Antoine R, Perić Bakulić M, Sanader Maršić Ž, Bonačić-Koutecký V, Blain M, Antel J, Maysinger D. Size and ligand effects of gold nanoclusters in alteration of organellar state and translocation of transcription factors in human primary astrocytes. Nanoscale 2021;13:3173-83. [PMID: 33527928 DOI: 10.1039/d0nr06401g] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ottestad W, Rognes IN, Pischke SE, Mollnes TE, Andersson U, Eken T. Biphasic Release of the Alarmin High Mobility Group Box 1 Protein Early After Trauma Predicts Poor Clinical Outcome. Crit Care Med 2019;47:e614-22. [PMID: 31162203 DOI: 10.1097/CCM.0000000000003800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Bian WY, Chen YP, Xu B, Tang J. Pretreatment with Propofol Reduces Pulmonary Injury in a Pig Model of Intestinal Ischemia-Reperfusion via Suppressing the High-Mobility Group Box 1 Protein (HMGB1)/Toll-Like Receptor 4 (TLR4)/Protein Kinase R (PKR) Signaling Pathway. Med Sci Monit 2021;27:e930478. [PMID: 34010266 DOI: 10.12659/MSM.930478] [Reference Citation Analysis]
13 Kamiya N, Kim HK. Elevation of Proinflammatory Cytokine HMGB1 in the Synovial Fluid of Patients With Legg-Calvé-Perthes Disease and Correlation With IL-6. JBMR Plus 2021;5:e10429. [PMID: 33615102 DOI: 10.1002/jbm4.10429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Ryan D, Koziol J, ElShamy WM. Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis. Sci Rep 2019;9:19150. [PMID: 31844158 DOI: 10.1038/s41598-019-55702-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Xie K, Chen YQ, Chai YS, Lin SH, Wang CJ, Xu F. HMGB1 suppress the expression of IL-35 by regulating Naïve CD4+ T cell differentiation and aggravating Caspase-11-dependent pyroptosis in acute lung injury. Int Immunopharmacol 2021;91:107295. [PMID: 33360086 DOI: 10.1016/j.intimp.2020.107295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Denning NL, Aziz M, Gurien SD, Wang P. DAMPs and NETs in Sepsis. Front Immunol 2019;10:2536. [PMID: 31736963 DOI: 10.3389/fimmu.2019.02536] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 29.3] [Reference Citation Analysis]
17 Jiao B, Guo S, Yang X, Sun L, Sai L, Yu G, Bo C, Zhang Y, Peng C, Jia Q, Dai Y. The role of HMGB1 on TDI-induced NLPR3 inflammasome activation via ROS/NF-κB pathway in HBE cells. Int Immunopharmacol 2021;98:107859. [PMID: 34153664 DOI: 10.1016/j.intimp.2021.107859] [Reference Citation Analysis]
18 Brück E, Lasselin J, Andersson U, Sackey PV, Olofsson PS; The HICUS study group. Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors. Intensive Care Med 2020;46:811-2. [DOI: 10.1007/s00134-020-05941-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Sun G, Shen JF, Wei XF, Qi GX. Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction. J Inflamm Res 2021;14:6397-407. [PMID: 34880642 DOI: 10.2147/JIR.S339133] [Reference Citation Analysis]
20 Qi X, Wang H, Xia L, Lin R, Li T, Guan C, Liu T. miR-30b-5p releases HMGB1 via UBE2D2/KAT2B/HMGB1 pathway to promote pro-inflammatory polarization and recruitment of macrophages. Atherosclerosis 2021;324:38-45. [PMID: 33812169 DOI: 10.1016/j.atherosclerosis.2021.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wu Y, Zhao Y, Yang HZ, Wang YJ, Chen Y. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose. Biosci Rep 2021;41:BSR20202924. [PMID: 33565572 DOI: 10.1042/BSR20202924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Paudel YN, Semple BD, Jones NC, Othman I, Shaikh MF. High mobility group box 1 ( HMGB 1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches. J Neurochem 2019;151:542-57. [DOI: 10.1111/jnc.14663] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
23 Liu T, Son M, Diamond B. HMGB1 in Systemic Lupus Erythematosus. Front Immunol 2020;11:1057. [PMID: 32536928 DOI: 10.3389/fimmu.2020.01057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Hao W, Zhu Y, Guo Y, Wang H. miR-1287-5p upregulation inhibits the EMT and pro-inflammatory cytokines in LPS-induced human nasal epithelial cells (HNECs). Transpl Immunol 2021;68:101429. [PMID: 34139308 DOI: 10.1016/j.trim.2021.101429] [Reference Citation Analysis]
25 Yu L, Zhou C, Wei Z, Shi Z. Effect of combined periodontal-orthodontic treatment on NOD-like receptor protein 3 and high mobility group box-1 expressions in patients with periodontitis and its clinical significance. Medicine (Baltimore) 2019;98:e17724. [PMID: 31689812 DOI: 10.1097/MD.0000000000017724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Liu DQ, Chen SP, Sun J, Wang XM, Chen N, Zhou YQ, Tian YK, Ye DW. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies. Pharmacol Res 2019;148:104385. [PMID: 31400402 DOI: 10.1016/j.phrs.2019.104385] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
27 Yuan X, Bhat OM, Lohner H, Zhang Y, Li PL. Downregulation of Lysosomal Acid Ceramidase Mediates HMGB1-Induced Migration and Proliferation of Mouse Coronary Arterial Myocytes. Front Cell Dev Biol 2020;8:111. [PMID: 32211403 DOI: 10.3389/fcell.2020.00111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhang Z, Zhou J, Verma V, Liu X, Wu M, Yu J, Chen D. Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury. Front Immunol 2021;12:774807. [PMID: 34925345 DOI: 10.3389/fimmu.2021.774807] [Reference Citation Analysis]
29 Vitali R, Terrin G, Palone F, Laudadio I, Cucchiara S, Boscarino G, Di Chiara M, Stronati L. Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates. Front Pediatr 2021;9:672131. [PMID: 34178888 DOI: 10.3389/fped.2021.672131] [Reference Citation Analysis]
30 Yang H, Liu H, Zeng Q, Imperato GH, Addorisio ME, Li J, He M, Cheng KF, Al-Abed Y, Harris HE, Chavan SS, Andersson U, Tracey KJ. Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation. Mol Med 2019;25:13. [PMID: 30975096 DOI: 10.1186/s10020-019-0081-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
31 Quan H, Bae HB, Hur YH, Lee KH, Lee CH, Jang EA, Jeong S. Stearoyl lysophosphatidylcholine inhibits LPS-induced extracellular release of HMGB1 through the G2A/calcium/CaMKKβ/AMPK pathway. Eur J Pharmacol 2019;852:125-33. [PMID: 30797785 DOI: 10.1016/j.ejphar.2019.02.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Ren Q, Jiang X, Paudel YN, Gao X, Gao D, Zhang P, Sheng W, Shang X, Liu K, Zhang X, Jin M. Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish. J Ethnopharmacol 2022;:115234. [PMID: 35358621 DOI: 10.1016/j.jep.2022.115234] [Reference Citation Analysis]
33 Lindhout IA, Murray TE, Richards CM, Klegeris A. Potential neurotoxic activity of diverse molecules released by microglia. Neurochem Int 2021;148:105117. [PMID: 34186114 DOI: 10.1016/j.neuint.2021.105117] [Reference Citation Analysis]
34 Huang YA, Chen JC, Wu CC, Hsu CW, Ko AM, Chen LC, Kuo ML. Reducing Lung ATP Levels and Alleviating Asthmatic Airway Inflammation through Adeno-Associated Viral Vector-Mediated CD39 Expression. Biomedicines 2021;9:656. [PMID: 34201190 DOI: 10.3390/biomedicines9060656] [Reference Citation Analysis]
35 Cheng X, Liu N, Liu H, Huang N, Sun X, Zhang G. Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin. Bioorg Chem 2020;100:103914. [PMID: 32417523 DOI: 10.1016/j.bioorg.2020.103914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lee JD, Liu N, Levin SC, Ottosson L, Andersson U, Harris HE, Woodruff TM. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 2019;16:45. [PMID: 30782181 DOI: 10.1186/s12974-019-1435-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
37 Yang H, Andersson U, Brines M. Neurons Are a Primary Driver of Inflammation via Release of HMGB1. Cells 2021;10:2791. [PMID: 34685772 DOI: 10.3390/cells10102791] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Roszkowski L, Ciechomska M. Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis. Cells 2021;10:1860. [PMID: 34440629 DOI: 10.3390/cells10081860] [Reference Citation Analysis]
39 Xiong Y, Yang J, Tong H, Zhu C, Pang Y. HMGB1 augments cognitive impairment in sepsis-associated encephalopathy by binding to MD-2 and promoting NLRP3-induced neuroinflammation. Psychogeriatrics 2021. [PMID: 34931753 DOI: 10.1111/psyg.12794] [Reference Citation Analysis]
40 Wu Q, Yin CH, Li Y, Cai JQ, Yang HY, Huang YY, Zheng YX, Xiong K, Yu HL, Lu AP, Wang KX, Guan DG, Chen YP. Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis. Front Pharmacol 2021;12:769190. [PMID: 34938184 DOI: 10.3389/fphar.2021.769190] [Reference Citation Analysis]
41 Aasebø E, Birkeland E, Selheim F, Berven F, Brenner AK, Bruserud Ø. The Extracellular Bone Marrow Microenvironment-A Proteomic Comparison of Constitutive Protein Release by In Vitro Cultured Osteoblasts and Mesenchymal Stem Cells. Cancers (Basel) 2020;13:E62. [PMID: 33379263 DOI: 10.3390/cancers13010062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Cicco S, Cicco G, Racanelli V, Vacca A. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment. Mediators Inflamm 2020;2020:7527953. [PMID: 32724296 DOI: 10.1155/2020/7527953] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 22.0] [Reference Citation Analysis]
43 Paudel YN, Angelopoulou E, Piperi C, Othman I, Shaikh MF. HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities. Int J Mol Sci 2020;21:E4609. [PMID: 32610502 DOI: 10.3390/ijms21134609] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
44 Liu S, Gao J, Liu K, Zhang HL. Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target. Mech Ageing Dev 2021;199:111560. [PMID: 34411603 DOI: 10.1016/j.mad.2021.111560] [Reference Citation Analysis]
45 Davis HM, Essex AL, Valdez S, Deosthale PJ, Aref MW, Allen MR, Bonetto A, Plotkin LI. Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice. Bone 2019;124:89-102. [PMID: 31028960 DOI: 10.1016/j.bone.2019.04.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
46 Huang X, Ni B, Mao Z, Xi Y, Chu X, Zhang R, Ma X, You H. NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway. J Cell Mol Med 2019;23:7525-34. [PMID: 31454155 DOI: 10.1111/jcmm.14621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
47 Wang J, Zhu D, Yin J, Ma C, Peng X, Zou H, Cao Y, Xu X. Upregulated HMGB1 levels in maternal-fetal interface of patients with unexplained recurrent spontaneous abortion from different sources. J Matern Fetal Neonatal Med 2021;:1-8. [PMID: 33944653 DOI: 10.1080/14767058.2021.1918084] [Reference Citation Analysis]
48 Zhang J, Li Q, Zou YR, Wu SK, Lu XH, Li GS, Wang J. HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils. Int Immunopharmacol 2021;94:107433. [PMID: 33592404 DOI: 10.1016/j.intimp.2021.107433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ho G, Ali A, Takamatsu Y, Wada R, Masliah E, Hashimoto M. Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2. Drug Discov Today 2021;26:2036-44. [PMID: 33775925 DOI: 10.1016/j.drudis.2021.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cazzato G, Colagrande A, Cimmino A, Cicco G, Scarcella VS, Tarantino P, Lospalluti L, Romita P, Foti C, Demarco A, Sablone S, Candance PMV, Cicco S, Lettini T, Ingravallo G, Resta L. HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study. Biomolecules 2021;11:1219. [PMID: 34439887 DOI: 10.3390/biom11081219] [Reference Citation Analysis]
51 Volmari A, Foelsch K, Zierz E, Yan K, Qi M, Bartels K, Kondratowicz S, Boettcher M, Reimers D, Nishibori M, Liu K, Schwabe RF, Lohse AW, Huber S, Mittruecker HW, Huebener P. Leukocyte-Derived High-Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes. Hepatol Commun 2021. [PMID: 34558858 DOI: 10.1002/hep4.1777] [Reference Citation Analysis]
52 Chang P, Li S, Sun Q, Guo K, Wang H, Li S, Zhang L, Xie Y, Zheng X, Liu Y. Fully Reduced HMGB1-Containing Peptide-Based Polyurethane Scaffold with Minimal Functional Unit of Skin (MFUS) Enhances Large and Deep Wounded Skin Healing. Macromol Biosci 2021;:e2100403. [PMID: 34783444 DOI: 10.1002/mabi.202100403] [Reference Citation Analysis]
53 Paudel YN, Angelopoulou E, Akyuz E, Piperi C, Othman I, Shaikh MF. Role of Innate Immune Receptor TLR4 and its endogenous ligands in epileptogenesis. Pharmacol Res 2020;160:105172. [PMID: 32871246 DOI: 10.1016/j.phrs.2020.105172] [Reference Citation Analysis]
54 Sha S, Tan J, Miao Y, Zhang Q. The Role of Autophagy in Hypoxia-Induced Neuroinflammation. DNA Cell Biol 2021;40:733-9. [PMID: 33989049 DOI: 10.1089/dna.2020.6186] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Yang H, Zeng Q, Silverman HA, Gunasekaran M, George SJ, Devarajan A, Addorisio ME, Li J, Tsaava T, Shah V, Billiar TR, Wang H, Brines M, Andersson U, Pavlov VA, Chang EH, Chavan SS, Tracey KJ. HMGB1 released from nociceptors mediates inflammation. Proc Natl Acad Sci U S A 2021;118:e2102034118. [PMID: 34385304 DOI: 10.1073/pnas.2102034118] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
56 Chen C, Wang S, Chen J, Liu X, Zhang M, Wang X, Xu W, Zhang Y, Li H, Pan X, Si M. Escin suppresses HMGB1-induced overexpression of aquaporin-1 and increased permeability in endothelial cells. FEBS Open Bio 2019;9:891-900. [PMID: 30972964 DOI: 10.1002/2211-5463.12622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
57 Dai S, Zheng Y, Wang Y, Chen Z. HMGB1, neuronal excitability and epilepsy. Acta Epileptologica 2021;3. [DOI: 10.1186/s42494-021-00048-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Krylatov AV, Tsibulnikov SY, Mukhomedzyanov AV, Boshchenko AA, Goldberg VE, Jaggi AS, Erben RG, Maslov LN. The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling. J Cardiovasc Pharmacol Ther 2021;26:131-48. [PMID: 32840121 DOI: 10.1177/1074248420952243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Zhou C, Yang Q. Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis. J Int Med Res 2021;49:300060521993312. [PMID: 33682495 DOI: 10.1177/0300060521993312] [Reference Citation Analysis]
60 van den Berg DF, Te Velde AA. Severe COVID-19: NLRP3 Inflammasome Dysregulated. Front Immunol 2020;11:1580. [PMID: 32670297 DOI: 10.3389/fimmu.2020.01580] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 28.5] [Reference Citation Analysis]
61 Arnold K, Liao YE, Liu J. Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage. Biomedicines 2020;8:E503. [PMID: 33207634 DOI: 10.3390/biomedicines8110503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kianian F, Kadkhodaee M, Sadeghipour HR, Karimian SM, Seifi B. An overview of high-mobility group box 1, a potent pro-inflammatory cytokine in asthma. J Basic Clin Physiol Pharmacol 2020;31. [PMID: 32651983 DOI: 10.1515/jbcpp-2019-0363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Paudel YN, Angelopoulou E, Semple B, Piperi C, Othman I, Shaikh MF. Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders. ACS Chem Neurosci 2020;11:485-500. [PMID: 31972087 DOI: 10.1021/acschemneuro.9b00640] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
64 Mei L, He M, Zhang C, Miao J, Wen Q, Liu X, Xu Q, Ye S, Ye P, Huang H, Lin J, Zhou X, Zhao K, Chen D, Zhou J, Li C, Li H. Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p. Sci Rep 2019;9:19370. [PMID: 31852965 DOI: 10.1038/s41598-019-55980-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
65 Zhang GZ, Liu MQ, Chen HW, Wu ZL, Gao YC, Ma ZJ, He XG, Kang XW. NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif 2021;54:e13057. [PMID: 34028920 DOI: 10.1111/cpr.13057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Wang Y, Jiang Z, Yan J, Ying S. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma. Dis Markers 2019;2019:4183157. [PMID: 30891101 DOI: 10.1155/2019/4183157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
67 Fu Z, Zhang J. Molecular hydrogen is a promising therapeutic agent for pulmonary disease. J Zhejiang Univ Sci B 2022;23:102-22. [PMID: 35187885 DOI: 10.1631/jzus.B2100420] [Reference Citation Analysis]
68 Chen L, Chen G, Kong X. Serum level of high mobility group box protein-1 and prognosis of patients with end-stage renal disease on hemodialysis and peritoneal dialysis. Medicine (Baltimore) 2021;100:e24275. [PMID: 33592871 DOI: 10.1097/MD.0000000000024275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Paudel YN, Angelopoulou E, Piperi C, Othman I, Shaikh MF. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results. Pharmacol Res 2020;156:104792. [PMID: 32278047 DOI: 10.1016/j.phrs.2020.104792] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
70 Tsubota M, Fukuda R, Hayashi Y, Miyazaki T, Ueda S, Yamashita R, Koike N, Sekiguchi F, Wake H, Wakatsuki S, Ujiie Y, Araki T, Nishibori M, Kawabata A. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants. J Neuroinflammation 2019;16:199. [PMID: 31666085 DOI: 10.1186/s12974-019-1581-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
71 Brück E, Svensson-Raskh A, Larsson JW, Caravaca AS, Gallina AL, Eberhardson M, Sackey PV, Olofsson PS. Plasma HMGB1 levels and physical performance in ICU survivors. Acta Anaesthesiol Scand 2021;65:921-7. [PMID: 33725363 DOI: 10.1111/aas.13815] [Reference Citation Analysis]
72 Lebda MA, Elmassry IH, Taha NM, Elfeky MS. Nanocurcumin alleviates inflammation and oxidative stress in LPS-induced mastitis via activation of Nrf2 and suppressing TLR4-mediated NF-κB and HMGB1 signaling pathways in rats. Environ Sci Pollut Res Int 2021. [PMID: 34482462 DOI: 10.1007/s11356-021-16309-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Zhang S, Hu L, Jiang J, Li H, Wu Q, Ooi K, Wang J, Feng Y, Zhu D, Xia C. HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia. J Neuroinflammation 2020;17:15. [PMID: 31924219 DOI: 10.1186/s12974-019-1673-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
74 Li Y, Zhang L, Tang J, Yang X, Huang J, Zhu T, Zhao F, Li S, Li X, Qu Y, Mu D. Role of toll-like receptor 4 in the regulation of the cell death pathway and neuroinflammation. Brain Research Bulletin 2019;148:79-90. [DOI: 10.1016/j.brainresbull.2019.03.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
75 Li L, Liu H, Tao W, Wen S, Fu X, Yu S. Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting. Front Pharmacol 2021;12:731386. [PMID: 34867338 DOI: 10.3389/fphar.2021.731386] [Reference Citation Analysis]
76 Pei X, Jiang H, Liu X, Li L, Li C, Xiao X, Li D, Tang S. Targeting HMGB1 inhibits T-2 toxin-induced neurotoxicity via regulation of oxidative stress, neuroinflammation and neuronal apoptosis. Food Chem Toxicol 2021;151:112134. [PMID: 33762183 DOI: 10.1016/j.fct.2021.112134] [Reference Citation Analysis]
77 Paudel YN, Angelopoulou E, Piperi C, Balasubramaniam VR, Othman I, Shaikh MF. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. European Journal of Pharmacology 2019;858:172487. [DOI: 10.1016/j.ejphar.2019.172487] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 16.3] [Reference Citation Analysis]
78 Ramya R, Coral K, Bharathidevi SR. RAGE silencing deters CML-AGE induced inflammation and TLR4 expression in endothelial cells. Exp Eye Res 2021;206:108519. [PMID: 33639133 DOI: 10.1016/j.exer.2021.108519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Zhao F, Guo Z, Hou F, Fan W, Wu B, Qian Z. Magnoflorine Alleviates "M1" Polarized Macrophage-Induced Intervertebral Disc Degeneration Through Repressing the HMGB1/Myd88/NF-κB Pathway and NLRP3 Inflammasome. Front Pharmacol 2021;12:701087. [PMID: 34366853 DOI: 10.3389/fphar.2021.701087] [Reference Citation Analysis]
80 Patel PM, Connolly MR, Coe TM, Calhoun A, Pollok F, Markmann JF, Burdorf L, Azimzadeh A, Madsen JC, Pierson RN 3rd. Minimizing Ischemia Reperfusion Injury in Xenotransplantation. Front Immunol 2021;12:681504. [PMID: 34566955 DOI: 10.3389/fimmu.2021.681504] [Reference Citation Analysis]
81 Heil M, Vega-Muñoz I. Nucleic Acid Sensing in Mammals and Plants: Facts and Caveats. Int Rev Cell Mol Biol 2019;345:225-85. [PMID: 30904194 DOI: 10.1016/bs.ircmb.2018.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
82 Ding X, Li S, Zhu L. Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases. Cytokine Growth Factor Rev 2021:S1359-6101(21)00065-4. [PMID: 34503914 DOI: 10.1016/j.cytogfr.2021.08.003] [Reference Citation Analysis]
83 Paudel YN, Shaikh MF, Chakraborti A, Kumari Y, Aledo-Serrano Á, Aleksovska K, Alvim MKM, Othman I. HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction. Front Neurosci 2018;12:628. [PMID: 30271319 DOI: 10.3389/fnins.2018.00628] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 23.3] [Reference Citation Analysis]
84 Yang Z, Simovic MO, Edsall PR, Liu B, Cancio TS, Batchinsky AI, Cancio LC, Li Y. HMGB1 Inhibition to Ameliorate Organ Failure and Increase Survival in Trauma. Biomolecules 2022;12:101. [DOI: 10.3390/biom12010101] [Reference Citation Analysis]
85 Chen S, Zhu J, Sun LQ, Liu S, Zhang T, Jin Y, Huang C, Li D, Yao H, Huang J, Qin Y, Zhou M, Chen G, Zhang Q, Ma F. LincRNA-EPS alleviates severe acute pancreatitis by suppressing HMGB1-triggered inflammation in pancreatic macrophages. Immunology 2021;163:201-19. [PMID: 33512718 DOI: 10.1111/imm.13313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
86 Li L, Lu YQ. The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity. Front Immunol 2020;11:601815. [PMID: 33552058 DOI: 10.3389/fimmu.2020.601815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
87 Yang H, Wang H, Andersson U. Targeting Inflammation Driven by HMGB1. Front Immunol 2020;11:484. [PMID: 32265930 DOI: 10.3389/fimmu.2020.00484] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 30.5] [Reference Citation Analysis]
88 Koch A, Tacke F. Response to the "Letter to the editor regarding article, 'High-mobility group box 1 as a biomarker in critically ill patients'.". J Clin Lab Anal 2019;33:e22820. [PMID: 30474271 DOI: 10.1002/jcla.22820] [Reference Citation Analysis]
89 Li Y, Xu B, Yang J, Wang L, Tan X, Hu X, Sun L, Chen S, Zhu L, Chen X, Chen G. Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release. Pharmacol Res 2021;173:105867. [PMID: 34481074 DOI: 10.1016/j.phrs.2021.105867] [Reference Citation Analysis]
90 Belmadani S, Matrougui K. Role of High Mobility Group Box 1 in Cardiovascular Diseases. Inflammation 2022. [PMID: 35386038 DOI: 10.1007/s10753-022-01668-3] [Reference Citation Analysis]
91 Reinhart NM, Akinyemi IA, Frey TR, Xu H, Agudelo C, Brathwaite J, Burton EM, Burgula S, McIntosh MT, Bhaduri-McIntosh S. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells. Virology 2022;566:136-42. [PMID: 34922257 DOI: 10.1016/j.virol.2021.12.002] [Reference Citation Analysis]
92 Paudel YN, Othman I, Shaikh MF. Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model. Front Pharmacol 2020;11:613009. [PMID: 33732146 DOI: 10.3389/fphar.2020.613009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Heil M, Brockmeyer NH. Self-DNA Sensing Fuels HIV-1-Associated Inflammation. Trends Mol Med 2019;25:941-54. [PMID: 31300343 DOI: 10.1016/j.molmed.2019.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Bi X, Jiang B, Zhou J, Fan X, Yan X, Liang J, Luo L, Yin Z. CBP Bromodomain Inhibition Rescues Mice From Lethal Sepsis Through Blocking HMGB1-Mediated Inflammatory Responses. Front Immunol 2020;11:625542. [PMID: 33603756 DOI: 10.3389/fimmu.2020.625542] [Reference Citation Analysis]
95 Su Y, Geng L, Ma Y, Yu X, Kang Z, Kang Z. Identification of circular RNA circVPS33A as a modulator in house dust mite-induced injury in human bronchial epithelial cells. Exp Lung Res 2021;47:368-81. [PMID: 34511010 DOI: 10.1080/01902148.2021.1974125] [Reference Citation Analysis]
96 Makris G, Chouliaras G, Apostolakou F, Papageorgiou C, Chrousos GP, Papassotiriou I, Pervanidou P. Increased Serum Concentrations of High Mobility Group Box 1 (HMGB1) Protein in Children with Autism Spectrum Disorder. Children (Basel) 2021;8:478. [PMID: 34198762 DOI: 10.3390/children8060478] [Reference Citation Analysis]
97 Chen R, Sun Y, Lv J, Dou X, Dai M, Sun S, Lin Y. Effects of Dexmedetomidine on Immune Cells: A Narrative Review. Front Pharmacol 2022;13:829951. [DOI: 10.3389/fphar.2022.829951] [Reference Citation Analysis]
98 Wang Z, Yang X, Wang X, Liang F, Tang Y. Glycyrrhizin attenuates caspase-11-dependent immune responses and coagulopathy by targeting high mobility group box 1. Int Immunopharmacol 2022;107:108713. [PMID: 35339905 DOI: 10.1016/j.intimp.2022.108713] [Reference Citation Analysis]
99 Sayce AC, Martinez FO, Tyrrell BE, Perera N, Hill ML, Dwek RA, Miller JL, Zitzmann N. Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response. Immunology 2021. [PMID: 34287854 DOI: 10.1111/imm.13393] [Reference Citation Analysis]
100 Zhang J, Xu X, Huang X, Zhu H, Chen H, Wang W, Liu Y. Analysis of microRNA expression profiles in porcine PBMCs after LPS stimulation. Innate Immun 2020;26:435-46. [PMID: 31969027 DOI: 10.1177/1753425920901560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Li C, Li L, Lan T. Co-treatment with disulfiram and glycyrrhizic acid suppresses the inflammatory response of chondrocytes. J Orthop Surg Res 2021;16:132. [PMID: 33579316 DOI: 10.1186/s13018-021-02262-3] [Reference Citation Analysis]
102 Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting. Cells 2020;9:E383. [PMID: 32046119 DOI: 10.3390/cells9020383] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
103 Štros M, Polanská EV, Hlaváčová T, Skládal P. Progress in Assays of HMGB1 Levels in Human Plasma—The Potential Prognostic Value in COVID-19. Biomolecules 2022;12:544. [DOI: 10.3390/biom12040544] [Reference Citation Analysis]
104 Paudel YN, Angelopoulou E, C BK, Piperi C, Othman I. High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potential. Life Sciences 2019;238:116924. [DOI: 10.1016/j.lfs.2019.116924] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
105 Sun Q, Ji YC, Wang ZL, She X, He Y, Ai Q, Li LQ. Sodium Butyrate Alleviates Intestinal Inflammation in Mice with Necrotizing Enterocolitis. Mediators Inflamm 2021;2021:6259381. [PMID: 34675753 DOI: 10.1155/2021/6259381] [Reference Citation Analysis]
106 Solmaz V, Kaya M, Uslu FB, Atasoy O, Erbaş O. Papaverine Has Therapeutic Potential for Sepsis-Induced Neuropathy in Rats, Possibly via the Modulation of HMGB1-RAGE Axis and Its Antioxidant Prosperities. J Invest Surg 2020;:1-7. [PMID: 32842806 DOI: 10.1080/08941939.2020.1809751] [Reference Citation Analysis]
107 Li J, Sparkenbaugh EM, Su G, Zhang F, Xu Y, Xia K, He P, Baytas S, Pechauer S, Padmanabhan A, Linhardt RJ, Pawlinski R, Liu J. Enzymatic Synthesis of Chondroitin Sulfate E to Attenuate Bacteria Lipopolysaccharide-Induced Organ Damage. ACS Cent Sci 2020;6:1199-207. [PMID: 32724854 DOI: 10.1021/acscentsci.0c00712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
108 Zhou Y, Wang T, Wang Y, Meng F, Ying M, Han R, Hao P, Wang L, Li X. Blockade of extracellular high-mobility group box 1 attenuates inflammation-mediated damage and haze grade in mice with corneal wounds. Int Immunopharmacol 2020;83:106468. [PMID: 32279044 DOI: 10.1016/j.intimp.2020.106468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
109 Anfinogenova ND, Quinn MT, Schepetkin IA, Atochin DN. Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation. Cells 2020;9:E2350. [PMID: 33114371 DOI: 10.3390/cells9112350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Land WG. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution. Mol Diagn Ther 2020;24:251-62. [PMID: 32248387 DOI: 10.1007/s40291-020-00460-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
111 Olejarz W, Łacheta D, Głuszko A, Migacz E, Kukwa W, Szczepański MJ, Tomaszewski P, Nowicka G. RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy. BioMed Research International 2018;2018:1-10. [DOI: 10.1155/2018/7675286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
112 Migayron L, Boniface K, Seneschal J. Vitiligo, From Physiopathology to Emerging Treatments: A Review. Dermatol Ther (Heidelb) 2020;10:1185-98. [PMID: 32949337 DOI: 10.1007/s13555-020-00447-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
113 Gan P, Ding L, Hang G, Xia Q, Huang Z, Ye X, Qian X. Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease. Front Pharmacol 2020;11:776. [PMID: 32528295 DOI: 10.3389/fphar.2020.00776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
114 Chibaatar E, Le K, Abdoulaye IA, Wu S, Guo Y. Melatonin Ameliorates Lipopolysaccharide-Induced Microglial Inflammation via Triggering SIRT1/HMGB1 Signaling Axis. J Mol Neurosci 2021;71:691-701. [PMID: 32910356 DOI: 10.1007/s12031-020-01699-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Kaur I, Behl T, Bungau S, Kumar A, Mehta V, Setia D, Uddin MS, Zengin G, Aleya L, Arora S. Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis. Life Sci 2020;258:118164. [PMID: 32739467 DOI: 10.1016/j.lfs.2020.118164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
116 Zhang J, Li F, Nie D, Onishi K, Hogan MV, Wang JH. Effect of Metformin on Development of Tendinopathy Due to Mechanical Overloading in an Animal Model. Foot Ankle Int 2020;41:1455-65. [PMID: 33180557 DOI: 10.1177/1071100720966318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Wang P, Hao P, Chen X, Li L, Zhou Y, Zhang X, Zhu L, Ying M, Han R, Wang L, Li X. Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn. Front Pharmacol 2022;13:841267. [DOI: 10.3389/fphar.2022.841267] [Reference Citation Analysis]
118 Aulin C, Lassacher T, Palmblad K, Erlandsson Harris H. Early stage blockade of the alarmin HMGB1 reduces cartilage destruction in experimental OA. Osteoarthritis Cartilage 2020;28:698-707. [PMID: 31982563 DOI: 10.1016/j.joca.2020.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
119 Mi L, Zhang Y, Xu Y, Zheng X, Zhang X, Wang Z, Xue M, Jin X. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury. Biomed Pharmacother 2019;116:109005. [PMID: 31136947 DOI: 10.1016/j.biopha.2019.109005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
120 Andersson U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26:42. [PMID: 32380958 DOI: 10.1186/s10020-020-00172-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 42.0] [Reference Citation Analysis]
121 Wu M, Zhang P, Wang P, Fang Z, Zhu Y. Identification of Flap Endonuclease 1 With Diagnostic and Prognostic Value in Breast Cancer. Front Oncol 2021;11:603114. [PMID: 34277392 DOI: 10.3389/fonc.2021.603114] [Reference Citation Analysis]
122 Sowinska A, Rensing M, Klevenvall L, Neog M, Lundbäck P, Harris HE. Cleavage of HMGB1 by Proteolytic Enzymes Associated with Inflammatory Conditions. Front Immunol 2020;11:448262. [PMID: 33391251 DOI: 10.3389/fimmu.2020.448262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]